Compare LEGN & ADT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEGN | ADT |
|---|---|---|
| Founded | 2014 | 1874 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.4B |
| IPO Year | 2020 | 2017 |
| Metric | LEGN | ADT |
|---|---|---|
| Price | $18.54 | $6.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $63.08 | $8.38 |
| AVG Volume (30 Days) | 1.5M | ★ 9.0M |
| Earning Date | 01-01-0001 | 06-04-2026 |
| Dividend Yield | N/A | ★ 3.25% |
| EPS Growth | N/A | ★ 29.63 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,128,607,000.00 |
| Revenue This Year | $46.27 | $5.00 |
| Revenue Next Year | $28.77 | $3.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.70 |
| 52 Week Low | $16.24 | $6.27 |
| 52 Week High | $45.30 | $8.94 |
| Indicator | LEGN | ADT |
|---|---|---|
| Relative Strength Index (RSI) | 46.94 | 36.32 |
| Support Level | $17.46 | $6.27 |
| Resistance Level | $21.58 | $8.30 |
| Average True Range (ATR) | 0.75 | 0.23 |
| MACD | 0.09 | -0.04 |
| Stochastic Oscillator | 36.86 | 22.59 |
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name.